Michael A Brown

Array ( [id] => 7172113 [patent_doc_number] => 20050203038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Modulation of ACE2 expression' [patent_app_type] => utility [patent_app_number] => 10/798923 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21263 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203038.pdf [firstpage_image] =>[orig_patent_app_number] => 10798923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310480 [patent_doc_number] => 20040142898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Antisense modulation of HKR1 expression' [patent_app_type] => new [patent_app_number] => 10/772542 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24909 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142898.pdf [firstpage_image] =>[orig_patent_app_number] => 10772542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329861 [patent_doc_number] => 20040254137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Antisense modulation of FLIP-c expression' [patent_app_type] => new [patent_app_number] => 10/695568 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27481 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254137.pdf [firstpage_image] =>[orig_patent_app_number] => 10695568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469190 [patent_doc_number] => 20040102412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Antisense modulation of GFAT expression' [patent_app_type] => new [patent_app_number] => 10/688706 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 75770 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102412.pdf [firstpage_image] =>[orig_patent_app_number] => 10688706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269832 [patent_doc_number] => 20040058350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Regulation of human secretin receptor-like gpcr' [patent_app_type] => new [patent_app_number] => 10/398455 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25871 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058350.pdf [firstpage_image] =>[orig_patent_app_number] => 10398455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336863 [patent_doc_number] => 20040132681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antisense modulation of beta-site APP-cleaving enzyme 2 expression' [patent_app_type] => new [patent_app_number] => 10/663452 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31095 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132681.pdf [firstpage_image] =>[orig_patent_app_number] => 10663452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127272 [patent_doc_number] => 20050059016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Structural motifs and oligomeric compounds and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/660059 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39828 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059016.pdf [firstpage_image] =>[orig_patent_app_number] => 10660059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325216 [patent_doc_number] => 20040138162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method of resisting osteoclast formation' [patent_app_type] => new [patent_app_number] => 10/650277 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7897 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138162.pdf [firstpage_image] =>[orig_patent_app_number] => 10650277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346716 [patent_doc_number] => 20040192628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Antisense modulation of focal adhesion kinase expression' [patent_app_type] => new [patent_app_number] => 10/646569 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16042 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192628.pdf [firstpage_image] =>[orig_patent_app_number] => 10646569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383097 [patent_doc_number] => 20040029277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Antisense modulation of NAC expression' [patent_app_type] => new [patent_app_number] => 10/633913 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029277.pdf [firstpage_image] =>[orig_patent_app_number] => 10633913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403738 [patent_doc_number] => 20040023918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of inhibitor-kappa B kinase-gamma expression' [patent_app_type] => new [patent_app_number] => 10/628841 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023918.pdf [firstpage_image] =>[orig_patent_app_number] => 10628841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025533 [patent_doc_number] => 20050019927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER' [patent_app_type] => utility [patent_app_number] => 10/604340 [patent_app_country] => US [patent_app_date] => 2003-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39606 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019927.pdf [firstpage_image] =>[orig_patent_app_number] => 10604340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355093 [patent_doc_number] => 20040048823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Anticancer agent comprising mycolactone' [patent_app_type] => new [patent_app_number] => 10/416513 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6350 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048823.pdf [firstpage_image] =>[orig_patent_app_number] => 10416513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7377866 [patent_doc_number] => 20040220123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Tissue-specific and pathogens-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/257480 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 42996 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220123.pdf [firstpage_image] =>[orig_patent_app_number] => 10257480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770405 [patent_doc_number] => 20030216345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Histone deacetylase inhibitor and use thereof' [patent_app_type] => new [patent_app_number] => 10/438075 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6575 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216345.pdf [firstpage_image] =>[orig_patent_app_number] => 10438075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865558 [patent_doc_number] => 20030191084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'High affinity nucleic acid ligands of complement system proteins' [patent_app_type] => new [patent_app_number] => 10/435750 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19546 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191084.pdf [firstpage_image] =>[orig_patent_app_number] => 10435750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770404 [patent_doc_number] => 20030216344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof' [patent_app_type] => new [patent_app_number] => 10/402016 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 15482 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216344.pdf [firstpage_image] =>[orig_patent_app_number] => 10402016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401049 [patent_doc_number] => 20040019004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3' [patent_app_type] => new [patent_app_number] => 10/390060 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12633 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019004.pdf [firstpage_image] =>[orig_patent_app_number] => 10390060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852039 [patent_doc_number] => 20030144242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antisense modulation of MEKK4 expression' [patent_app_type] => new [patent_app_number] => 10/371474 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24984 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144242.pdf [firstpage_image] =>[orig_patent_app_number] => 10371474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378953 [patent_doc_number] => 20040028680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export' [patent_app_type] => new [patent_app_number] => 10/353458 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22883 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028680.pdf [firstpage_image] =>[orig_patent_app_number] => 10353458 [rel_patent_id] =>[rel_patent_doc_number] =>)